Bucharest, 11 January 2018: Mușat & Asociații advised Penta Investments, a Central European investment fund, on the acquisition of A&D Pharma by Dr.Max, one of the biggest pharmacy chains in CEE, owned by Penta Investments
The value of the transaction has not been disclosed by the parties involved and shall be completed after the approval of the Competition Council.
The Mușat & Asociații team involved in the project was coordinated by Mr. Gheorghe Mușat, Senior Partner, seconded by Răzvan Stoicescu, Partner, and Adrian Danciu, Senior Associate. As regards the competition and life sciences component of the transaction, the team was coordinated by Paul Buta, Partner, and included Dan Minoiu, Manuela Lupeanu and Răzvan Pele, Managing Associates within Mușat & Asociații.
Josef Zíma, M&A Manager Dr. Max stated: “The transaction has truly benefitted from the quality of the legal services provided by Mușat & Asociații, and the team, of which we mention Răzvan Stoicescu and Adrian Danciu, has been really enthusiastic, diligent and hardworking during the entire process.”
“We are honoured to have assisted Penta Investments in this transaction that consolidates the position of Dr. Max Group as leader of the pharmaceutical market and we thank our client for the trust it has placed in us”, stated Mr. Gheorghe Mușat, Senior Partner at the law firm Mușat & Asociații and coordinator of the transaction.
The pharmaceutical group Dr. Max currently operates over 1300 pharmacies in Central and Eastern Europe and is held by Penta Investments, an investment fund from Central Europe incorporated in 1994. Besides the health sector, the fund also carries out activities in fields such as financial services, production, retail, real estate development and mass-media.
